Results 221 to 230 of about 278,007 (254)

Perioperative Risks of Concurrent Pancreatic and Hepatic Resections for Neuroendocrine Tumors

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Pancreatic neuroendocrine tumors (pNETs) account for 1%–2% of pancreatic tumors, with an increasing incidence. The safety of concurrent pancreas‐liver resections remains uncertain. This study evaluated the national outcomes of concurrent pancreatectomy and liver‐directed surgery for pNETs. Methods ACS‐NSQIP (2019–2023)
Amir Ebadinejad   +4 more
wiley   +1 more source

Outcomes Following Total Pancreatectomy With and Without Vascular Resection: A NSQIP Analysis Comparing Trends in Patient Selection and Outcomes Over 5 Years

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Advances in neoadjuvant therapy and surgical techniques have led to more total pancreatectomies (TP) with vascular resection for pancreatic cancer. This study assesses contemporary outcomes of TP with venous (VR) and arterial (AR) resections compared to non‐vascular resection (NVR).
Zofia Czarnecka   +3 more
wiley   +1 more source

Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report. [PDF]

open access: yesSurg Case Rep
Shirakawa Y   +14 more
europepmc   +1 more source

Stathmin 1 across neuroendocrine neoplasms: biological, pathological and translational insights. [PDF]

open access: yesFront Endocrinol (Lausanne)
La Salvia A   +7 more
europepmc   +1 more source

Ablative magnetic resonance-guided radiation for gastrointestinal neuroendocrine tumors: assessing local control and toxicity. [PDF]

open access: yesClin Transl Radiat Oncol
Peterson JS   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy